← Back to Patent Explorer
US3978041A Expired / Lapsed US ⏱️ 0.0 years remaining

Phenoxy substituted glycosides

Assignee: Novartis Corp
•
Filing: 1975-02-03
•
Granted: 1976-08-31
•
Expires: 1995-02-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1-Phenoxy-2-hydroxy-3-amino-propanes of the formula I ##EQU1## wherein R 1 is a sugar residue and R 2 is isopropyl, tert.-butyl or α-methyl-phenethyl optionally substituted in the phenyl part, and the salts thereof are useful as positively inotropic agents, especially in the treatment of insufficiency of the cardiac muscle.

Inventors

  • 👤 Knut A. Jaeggi
  • 👤 Herbert Schroter
  • 👤 Franz Ostermayer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 01:19
CPC Classifications
C; C07; C07H; C07H15/00; C07H15/20

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 61 words
A compound which is a 1-phenoxy-2-hydroxy-3-amino-propane of the formula ##EQU5## wherein R 1 represents 1-glucopyranosidyl, 2,3,4,6-tetra-O-alkanoylated 1-glucopyranosidyl, the alkanoyl radical of which having up to four carbon atoms, or 2,4-O,O-alkylidene substituted 1-glucopyranosidyl, the alkylidene radical of which having up to four carbon atoms, or 2,4-O-benzylidene substituted 1-glucopyranosidyl, R 2 is isopropyl, tert.-butyl, α-methylphenethyl or 1-methyl-3-phenyl-propyl, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 61 words
A compound which is a 1-phenoxy-2-hydroxy-3-amino-propane of the formula ##EQU5## wherein R 1 represents 1-glucopyranosidyl, 2,3,4,6-tetra-O-alkanoylated 1-glucopyranosidyl, the alkanoyl radical of which having up to four carbon atoms, or 2,4-O,O-alkylidene substituted 1-glucopyranosidyl, the alkylidene radical of which having up to four carbon atoms, or 2,4-O-benzylidene substituted 1-glucopyranosidyl, R 2 is isopropyl, tert.-butyl, α-methylphenethyl or 1-methyl-3-phenyl-propyl, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 32 words
A compound as claimed in claim 1, wherein R 1 represents 1-glucopyranosidyl, 2,3,4,6-tetra-O-acetyl-1-glucopyranosidyl, 2,4-O-isopropylidene-1-glucopyranosidyl or 2,4-O-benzlidene-1-glucopyranosidyl, and R 2 is isopropyl, tert.-butyl or α-methylphenethyl or 1-methyl-3-phenyl-propyl, or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 25 words
A compound as claimed in claim 1, wherein R 1 is 1-glucopyranosidyl and R 2 is isopropyl or tert.-butyl, or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 15 words
A compound as claimed in claim 1 being 1-[p-(β-D-glucopyranosidyloxy)-phenoxy]-2-hydroxy-3-isopropylamino-propane, or a pharmaceutically acceptable salt thereof.
Claim 6
Dependent Claim 42 words
A compound as claimed in claim 1 being an optically active 1-phenoxy-2-hydroxy-3-aminopropane, having the S-configuration, of the formula I, wherein R 1 is O-acetyl-1-glucopyramosidyl or O-benzoyl-1-glucopyranosidyl and R 2 is isopropyl, tert.-butyl or α-methylphenethyl or 1-methyl-3-phenyl-propyl, or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim 15 words
A compound as claimed in claim 1 being 1-[p-(β-glucopyranosidyloxy)-phenoxy]-2S-hydroxy-3-isopropylaminio-propane, or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim 10 words
The N-cyclohexylsulphamic acid salt of the compound of claim 6.
Claim 9
Dependent Claim 9 words
The hydrochloride salt of the compound of claim 6.
Claim 10
Dependent Claim 15 words
A compound as claimed in claim 1 being 4-(3-Isopropylamino-2S-hydroxy-propoxy)-phenyl-2,3,4,6-tetra-O-acetyl-.beta.-D-glucopyranoside, or a pharmaceutically acceptable salt thereof.
Claim 11
Dependent Claim 9 words
The hydrochloride salt of the compound of claim 9.
Claim 12
Dependent Claim 70 words
A compound as claimed in claim 1 being an optically active 1-phenoxy-2-hydroxy-3-aminopropane having the S-configuration of the formula I, wherein R 1 represents 1-glucopyranosidyl, 2,3,4,6-tetra-O-alkanoylated 1-glucopyranosidyl, the alkanoyl radical of which having up to four carbon atoms, or 2,4-O,O-alkylidene substituted 1-glucopyranosidyl, the alkylidene radical of which having up to four carbon atoms, or 2,4-O,O-benzylidene substituted 1-glucopyranosidyl, R 2 is isopropyl, tert.-butyl, α-methylphenethyl or 1-methyl-3-phenyl-propyl, or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

US2252725A Cited
US3152115A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-08-31 1980-03-01 1980-08-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-08-31 1984-03-01 1984-08-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-08-31 1988-03-01 1988-08-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag